TAYLOR KRAMER: Open Payments
NPI 1942858998 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 9 payments from 9 companies in 2025. Trend: 2023 $543 · 2024 $631 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 1 | $54 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Geron Corporation | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: Iovera, Enhertu, RYTELO, DARZALEX, BRAFTOVI, MONOFERRIC, ELREXFIO, Trodelvy.
Industry payments across TX — which companies pay providers there.
